Sangamo Therapeutics, Inc. (SGMOQ)
0.1475
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Sangamo Therapeutics Market Cap : 61.11M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 61.11M |
| October 01, 2026 | 60.19M |
| September 30, 2026 | 60.90M |
| September 29, 2026 | 58.00M |
| September 28, 2026 | 59.28M |
| September 25, 2026 | 59.66M |
| September 24, 2026 | 60.94M |
| September 23, 2026 | 61.56M |
| September 22, 2026 | 60.44M |
| September 21, 2026 | 58.54M |
| September 18, 2026 | 60.03M |
| September 17, 2026 | 58.45M |
| September 16, 2026 | 61.15M |
| September 15, 2026 | 61.02M |
| September 14, 2026 | 61.11M |
| September 11, 2026 | 61.52M |
| September 10, 2026 | 64.38M |
| September 09, 2026 | 64.21M |
| September 08, 2026 | 66.66M |
| September 04, 2026 | 66.70M |
| September 03, 2026 | 68.85M |
| September 02, 2026 | 70.84M |
| September 01, 2026 | 67.94M |
| August 31, 2026 | 68.31M |
| August 28, 2026 | 66.49M |
| Date | Value |
|---|---|
| August 27, 2026 | 63.55M |
| August 26, 2026 | 62.35M |
| August 25, 2026 | 61.69M |
| August 24, 2026 | 66.28M |
| August 21, 2026 | 58.95M |
| August 20, 2026 | 66.37M |
| August 19, 2026 | 66.70M |
| August 18, 2026 | 66.08M |
| August 17, 2026 | 69.72M |
| August 14, 2026 | 72.50M |
| August 13, 2026 | 68.36M |
| August 12, 2026 | 63.59M |
| August 11, 2026 | 60.07M |
| August 10, 2026 | 48.88M |
| August 07, 2026 | 46.40M |
| August 06, 2026 | 46.19M |
| August 05, 2026 | 41.18M |
| August 04, 2026 | 36.91M |
| August 03, 2026 | 35.71M |
| July 31, 2026 | 30.32M |
| July 30, 2026 | 29.47M |
| July 29, 2026 | 28.50M |
| July 28, 2026 | 27.85M |
| July 27, 2026 | 26.72M |
| July 24, 2026 | 26.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
| Sarepta Therapeutics, Inc. | 1.848B |
| Anixa Biosciences, Inc. | 102.02M |
| Vicapsys Life Sciences, Inc. | 21.04M |
Market Cap Related Metrics
| PS Ratio | 1.375 |
| Price | 0.1475 |
| Earnings Yield | -259.7% |